This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heartdisease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.
A projected rise in heartdisease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. to 61% of the U.S. population.
The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heartattack 2. 2024 Jan 14. 8 The relationship between genetic liver fat and coronary heartdisease is explained by apoB-containing lipoproteins. 2024 Jan;388:117397. Clin Sci (Lond).
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Coronary inflammation is a crucial piece of the puzzle in predicting heartattack risk.
Getty Images milla1cf Thu, 05/16/2024 - 15:37 May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of economic and social conditions that influence individual and group differences in health status, known as social determinants of health. Over a period of 9.5
milla1cf Sun, 04/07/2024 - 18:20 April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated triglycerides, also known as hypertriglyceridemia , putting them at an increased risk for heartattacks and stroke.
The Intrepid TMVR is a heart valve that is designed to help alleviate mitral regurgitation so that blood can flow through the heart in the intended direction,” said Matthew Saybolt , M.D., FACC, principal site investigator and medical director, Structural HeartDisease Program, Jersey Shore University Medical Center. “It
milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heartattack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.
An improved understanding of heart development could help inform new clinical strategies in managing congenital heartdiseases, which are the most common type of birth defects, said research team leader Shang Wang from Stevens Institute of Technology. Express, 16, 499-519 (2024). Faubert, S.
Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. If a valve cannot open or close fully it can interfere with blood flow and cause a host of health issues, including heartattack and stroke. Image by Getty. million people.
Circulation, Volume 150, Issue Suppl_1 , Page A4140513-A4140513, November 12, 2024. Aims:Asian Americans experience disproportionate burdens of cardiovascular risk factors and cardiovascular disease (CVD). However, the trends in cardiovascular risks in adults from different Asian ethnic backgrounds remain understudied.
tim.hodson Tue, 10/01/2024 - 10:50 PHOTO CAPTION: The Elucid PlaqueIQ user interface is a fully interactive visualization of the patient’s coronary anatomy, showing specific plaque type and amount across various views to inform physician assessment of risk and patient-specific treatment pathway.
Statins are a mainstay of heartdisease prevention, yet experts estimate that less than half of patients who are eligible to receive the drugs are currently taking them.
Diabetic cardiomyopathy is a disease in which chronically high levels of blood glucose (hyperglycemia) damage the heart muscle, leading to heart failure over time. Patients had had Type 2 diabetes for an average of 14 years.
The TACT2 study was designed to replicate the results of a previous trial, TACT , which reported in 2012 that chelation reduced subsequent cardiovascular events after a heartattack. and Canadian patients with diabetes and a history of heartattack,” said Gervasio A. and Canada.
However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heartattack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries. About 32% had Type 2 diabetes.
Elsie Kodjoe, MD milla1cf Tue, 04/02/2024 - 18:20 April 2, 2024 — Individuals with heartdisease stand to gain the most from a low sodium diet but, on average, consume over twice the recommended daily sodium intake, according to a study being presented at the American College of Cardiology’s Annual Scientific Session.
Many studies have shown that people who engage in more physical activity are healthier and have fewer heartattacks and strokes than people who engage in less. This is equally true for people who have previously had a heartattack or a stroke or have heart failure or are at risk for cardiovascular disease.”
tim.hodson Thu, 12/05/2024 - 11:59 Dec. 4, 2024 – Cleerly has successfully closed its latest Series C extension funding round, raising a total of $106 million. Cleerly is dedicated to creating a new standard of care for heartdisease by using FDA-cleared solutions powered by artificial intelligence.
While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heartattack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,
CaRi-Plaque builds on Caristoscore CaRi-Hearttechnology, which a Lancet 2024 study proved can reveal hidden, high-risk markers of CAD progression predicting heartattacks up to a decade before they strike. For decades, heartdisease has been treated reactively, waiting for symptoms to appear before taking action.
milla1cf Wed, 04/24/2024 - 19:01 April 24, 2024 — Hello Heart , a digital leader in preventive heart health, today announced results from its latest study observing the benefits of scalable, accessible digital health tools for a growing senior population. Eighty percent of heartattacks and strokes are preventable.
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heartattack or stroke within three months of a prior heartattack, according to research presented at ACC.24, 24, the American College of Cardiology Annual Annual Scientific Session.
The answer is pretty simple, but most people get this wrong, and doing so increases their future risk of heartattack and strokes. Like other risk factors for heartdisease, the key is to maintain normal blood pressure for as long as possible. 2024 Nov;81(11):2329-2339. It is not enough. Lifetime Blood Pressure.
CAD is estimated to be responsible for one heartattack every 40 seconds and one out of every five deaths. 2, 3 Heartflow is working to ensure that its technology not only helps clinicians see CAD earlier but also transforms how they understand and manage the disease. References Centers for Disease Control and Prevention.
mtaschetta-millane Fri, 02/16/2024 - 09:40 February 16, 2024 — Cardio Diagnostics Holdings, Inc. , HeartRisk's ability to aggregate population-level heartattack risk, the presence of heartdisease detection, and intervention monitoring and management aligns with the financial incentives of shared-risk contracts.
Getty Images milla1cf Thu, 01/25/2024 - 20:44 January 25, 2024 — Agepha Pharma , a leading multinational pharmaceutical company with the first FDA-approved anti-inflammatory cardiovascular treatment ( LODOCO – colchicine, 0.5 But in three quarters of patients, there is no clear sign of significant narrowing at the time of CCTA.
Within the complex umbrella of cardiovascular disease, CAD is a type of heartdisease that develops when the coronary arteries narrow and the heart cannot deliver enough oxygen-rich blood to the heart. Use Heart to Act on Angina. Accessed May 2024. Available at: [link].
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. Suman Pasupuleti, M.D. and Europe. Circulation.
Image courtesy: Getty Images christine.book Thu, 02/08/2024 - 15:53 February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association ’s International Stroke Conference , ISC 2024 , shed light on the use of artificial intelligence ( AI ) to help guide treatment decisions for stroke patients.
Getty Images milla1cf Thu, 06/06/2024 - 21:40 June 6, 2024 — A substantial portion of young athletes are at risk of hypertension, according to a study presented at the American College of Cardiology’s Care of the Athletic Heart conference , taking place on June 6-8 in Washington. according to CardioSmart.org.
By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risk of heartdiseases, heartattacks and strokes. “We In this case, it aims to ‘silence’ LPA, a gene that tells the body to make a specific protein that is only found in Lp(a).
tim.hodson Wed, 10/30/2024 - 10:00 Oct. The opportunity is even greater in millions of lung CT scans,” said Dr. Morteza Naghavi, founder and president of HeartLung Technologies, and founder of nonprofit SHAPE (Society for HeartAttack Prevention and Eradication). added Dr. Naghavi.
Getty Images milla1cf Fri, 04/05/2024 - 09:57 April 5, 2024 — Johnson & Johnson and Shockwave Medical , Inc. IVL is a minimally invasive, catheter-based treatment for calcified arterial lesions, which can reduce blood flow and cause pain or heartattack. in 2024 and approximately $0.17
milla1cf Thu, 03/21/2024 - 11:08 March 21, 2024 — The U.S. Food and Drug Administration ( FDA ) announced that Abiomed is recalling the Instructions for Use for its Impella Left Sided Blood Pumps because the pump catheter may perforate (cut) the wall of the left ventricle in the heart.
Introduction: Addressing the Need for Improved LDL Management in the US There is a clear need for innovative treatments to combat cardiovascular disease (CVD). Heartdisease remains the leading cause of death for men and women. However, every 40 seconds, an individual in the US suffers a heartattack.
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heartattack, stroke and death for people with Peripheral Artery Disease (PAD).
Untreated risk factors have a larger impact on risk for death following a serious heart event among survivors of childhood cancer relative to the general population, and therefore we shouldn’t just assume that because someone is young they don’t need risk factors like high blood pressure or high cholesterol treated.”
Circulation, Volume 150, Issue Suppl_1 , Page A4139303-A4139303, November 12, 2024. Introduction:Historically, Middle-Eastern (ME) immigrants have been aggregated with Non-Hispanic White (NHW) individuals, masking disparities in cardiovascular diseases (CVD).
Circulation, Volume 150, Issue Suppl_1 , Page A4125581-A4125581, November 12, 2024. Background:Among patients presenting with atherosclerotic cardiovascular disease (ASCVD), the proportion of young individuals has increased in recent years.
He reported a history of “Wolf-Parkinson-White” and “heartattack” but said neither had been treated. Am Heart J 1999;137:799–805. Ventricular arrhythmias in ischemic heartdisease: mechanism, prevalence, significance, and management. These diagnoses were not found in his medical records nor even a baseline ECG.
Getty Images milla1cf Tue, 03/05/2024 - 13:15 March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heartattack and stroke, according to an observational study supported by the National Institutes of Health. Cannabis use could be an important, underappreciated source of heartdisease.”
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content